Company Overview and News


Add AXP
to your dashboard

Headline News

5th Prospective Trial Confirms Physician and Patient Satisfaction, Ease of Use and Convenience with AeroForm® Tissue Expander System

2017-10-09 prnewswire
PALO ALTO, Calif., Oct. 9, 2017 /PRNewswire/ -- AirXpanders, Inc. (ASX: AXP) (AirXpanders or Company), a medical device company focused on the design, manufacture, sale and distribution of the AeroForm® Tissue Expander System, today announced that new data on the use of its AeroForm® Tissue Expander System was presented during the 86th Plastic Surgery: The Meeting, the annual scientific meeting of the American Society of Plastic Surgery (ASPS), October 6-10, in Orlando, FL.

AirXpanders Announces Completion Of Manufacturing Transfer To Costa Rica

2017-09-28 devicespace
PALO ALTO, Calif., Sept. 28, 2017 /PRNewswire/ -- AirXpanders, Inc. (ASX: AXP) (AirXpanders or Company), a medical device company focused on the design, manufacture, sale and distribution of the AeroForm® Tissue Expander System, today announced that its manufacturing transfer to a contract manufacturer in Costa Rica is complete and manufacturing capability for its AeroForm device is operational. Additional production capacity will enable the company to cost-effectively manufacture a higher volume of AeroForm expanders to meet growing market demand for the product, which is now available in more than 100 U.

AirXpanders Announces Completion of Manufacturing Transfer to Costa Rica

2017-09-28 prnewswire
PALO ALTO, Calif., Sept. 28, 2017 /PRNewswire/ -- AirXpanders, Inc. (ASX: AXP) (AirXpanders or Company), a medical device company focused on the design, manufacture, sale and distribution of the AeroForm® Tissue Expander System, today announced that its manufacturing transfer to a contract manufacturer in Costa Rica is complete and manufacturing capability for its AeroForm device is operational. Additional production capacity will enable the company to cost-effectively manufacture a higher volume of AeroForm expanders to meet growing market demand for the product, which is now available in more than 100 U.

AirXpanders increases production capacity of its tissue expander system

2017-09-28 proactiveinvestors.com.au
AirXpanders Inc (ASX:AXP) has increased the production capacity of its AeroForm® Tissue Expander System after completing the manufacturing transfer to Costa Rica.  

New Publication Confirms Patient Ease of Use For AirXpanders' AeroForm Tissue Expander System

2017-09-16 devicespace
PALO ALTO, Calif., Sept. 12, 2017 /PRNewswire/ -- AirXpanders, Inc. (ASX: AXP) (AirXpanders or Company), a medical device company focused on the design, manufacture, sale and distribution of the AeroForm® Tissue Expander System, today announced that a new publication in the July/September issue of Plastic Surgical Nursing (PSN) reinforced that patients undergoing breast reconstruction found the AeroForm dosage controller easy to use for breast tissue expansion.

AirXpanders Announces AeroForm Now Available In More Than 100 Medical Institutions And Health Systems In The U.S.

2017-06-09 devicespace
PALO ALTO, Calif., June 9, 2017 /PRNewswire/ -- AirXpanders, Inc. (ASX: AXP) (AirXpanders or Company), a medical device company focused on the design, manufacture, sale and distribution of the AeroForm® Tissue Expander System, today updated the market on the progress of its commercial roll-out in the United States. AeroForm is now available in more than one hundred (100) medical institutions and health systems, located throughout the country.

AirXpanders launches unique medical device in the U.S.

2017-06-09 proactiveinvestors.com.au
AirXpanders (ASX:AXP) has rolled out its AeroForm Tissue Expander System in more than 100 medical institutions and health systems across the U.S.

AirXpanders Update On U.S. Commercial Launch Of The AeroForm Tissue Expander System for Breast Reconstruction

2017-04-05 devicespace
PALO ALTO, Calif, April 4, 2017 /PRNewswire/ -- AirXpanders, Inc. (ASX: AXP) (AirXpanders or Company), a medical device company focused on the design, manufacture, sale and distribution of the AeroForm® Tissue Expander System, is today providing an update on its full U.S. commercial launch of AeroForm.

AirXpanders' AeroForm Tissue Expander System Showcased At

2017-03-21 devicespace
PALO ALTO, Calif., March 21, 2017 /PRNewswire/ -- AirXpanders, Inc. (ASX: AXP) (AirXpanders or Company), a medical device company focused on the design, manufacture, sale and distribution of the AeroForm® Tissue Expander System, today announced that the AeroForm technology was featured at the prestigious Barcelona Breast Meeting (BBM), which took place March 16-17, in Barcelona, Spain.

AirXpanders' AeroForm Tissue Expander System For Breast Reconstruction Featured On "The Doctors" National Television Show

2017-03-10 devicespace
PALO ALTO, Calif., March 10, 2017 /PRNewswire/ -- AirXpanders, Inc. (ASX: AXP) (AirXpanders or Company), a medical device company focused on the design, manufacture, sale and distribution of the AeroForm® Tissue Expander System, today announced that AeroForm was featured on the "The Doctors", an Emmy-award winning television show distributed nationally in the U.S. by CBS. The segment aired on Thursday, March 9, 2017.

AirXpanders' AeroForm® Tissue Expander System for Breast Reconstruction Featured on "The Doctors" National Television Show

2017-03-10 prnewswire
PALO ALTO, Calif., March 10, 2017 /PRNewswire/ -- AirXpanders, Inc. (ASX: AXP) (AirXpanders or Company), a medical device company focused on the design, manufacture, sale and distribution of the AeroForm® Tissue Expander System, today announced that AeroForm was featured on the "The Doctors", an Emmy-award winning television show distributed nationally in the U.S. by CBS. The segment aired on Thursday, March 9, 2017.

American Express (AXP) Q4 Earnings: A Beat in the Cards?

2017-01-18 zacks
We expect American Express Company (AXP - Free Report) to beat earnings expectations when it reports its fourth-quarter and full-year 2016 results, after the market closes tomorrow. Over the past three months, shares of American Express gained 27.5%. The price reaction was largely driven by the post-election rally over optimism for faster growth in economy and benefit from potential tax cuts. Will the rally in stock price continue post fourth-quarter earnings release? It majorly depends on whether the firm is able to maintain its trend of beating earnings over the last four quarters.

Should You Buy American Express (AXP) Ahead of Earnings?

2017-01-18 zacks
Investors are always looking for stocks that are poised to beat at earnings season and American Express Company (AXP - Free Report) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.

Visa to Spread Further in Europe with Visa Europe Buyout

2016-06-22 zacks
Visa Inc. (V - Analyst Report) , a global payments technology company, has completed the acquisition of Visa Europe Ltd within the scheduled time. For Visa, reuniting with Visa Europe has been a crucial long-term growth strategy. The company stands to gain a competitive edge from Visa Europe’s strong business model. Already the leading card processor, the addition of Visa Europe will further boost Visa’s position in the industry with digital payment products, services and processing to about 17,100 financial institution clients and partners, 40 million merchant outlets, and 3.

AirXpanders Inc gets ready to raise

2016-06-06 proactiveinvestors.com.au
Medical devices company AirXpanders Inc (ASX:AXP) is heading to market with a trading halt. The ASX has granted a trading halt to prepare, with the company's shares placed in pre-open. The halt will remain in place until the opening of trade on Wednesday 8th June 2016, or earlier if an announcement is made to the market.